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ABSTRACT
We have been carrying out a cohort study in two towns in Hokkaido, called “The Tanno and Sobetsu study”, for
30 years or more and have reported many data on relationships between various lifestyle-related diseases and occur-
rence of cardiovascular disease. In this paper, we present data obtained from an epidemiological study on abdominal
obesity and metabolic syndrome (MetS) in the Japanese general population.
We investigated the prevalence of MetS in the towns of Tanno and Sobetsu.  Prevalence of MetS was 26.4% for men
and 8.8% for women.  These results are supported by the results of a national health and nutrition survey in Japan.
Risks of abdominal obesity for occurrence of type 2 diabetes and hypertension (HT) were investigated using our
cohort data.  The incidences of type 2 diabetes and HT were significantly higher in the abdominal obesity group than in
the non-abdominal obesity group.  The relative risk of occurrence of type 2 diabetes adjusted for age, sex, SBP, TC and
smoking was 2.06 for abdominal obesity, and the relative risk of occurrence of HT adjusted for some confounding fac-
tors was 2.33 for abdominal obesity.
We investigated the risk of MetS for occurrence of cardiac disease.  Cumulative survival rate in individuals with
MetS tended to be lower than that in individuals without MetS.  Hazards ratio in the individuals with MetS was 1.87
(95% CI: 0.87-4.00, p=0.108).  We also investigated the risk of MetS for occurrence of type 2 diabetes.  The relative
risk of MetS for occurrence of type 2 diabetes was 2.2 after adjustment for age, sex, smoking, total cholesterol and high
fasting plasma glucose (fasting plasma glucose ≥ 110 mg/dl).
We investigated the relationship between MetS and health-related quality of life (QOL).  The participants were
divided into two groups according to age, a non-elderly group (<65 years old) and an elderly group (3 65 years old) and
each of these groups was further divided into two groups, a non-MetS group and a MetS group.  The percentages of
individuals having decreased QOL summary score were compared among these groups.  In the non-elderly group,
there was no difference between percentages of individuals with decreased QOL summary score in the non-MetS group
and MetS group.  On the other hand, in the elderly group, the percentage of individuals with decreased QOL summary
score was significantly higher in the MetS group than in the non-MetS group.
In conclusion, the results presented in this paper suggest that management of abdominal obesity and MetS is
important for prevention of CVD events and decrease of health-related QOL.
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＊血圧高値：収縮期血圧 ≥ 130mmHgかつ/または　拡張期血圧 ≥ 85 mmHg 



















は男性で 1.94（95％ CI： 1.19-3.17），女性で 2.86
（95％CI： 1.56-5.24）であった．さらに脳卒中に対して
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